标题
Potential Prophylactic Treatments for COVID-19
作者
关键词
-
出版物
Viruses-Basel
Volume 13, Issue 7, Pages 1292
出版商
MDPI AG
发表日期
2021-07-05
DOI
10.3390/v13071292
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Early use of nitazoxanide in mild Covid-19 disease: randomised, placebo-controlled trial
- (2021) Patricia R. M. Rocco et al. EUROPEAN RESPIRATORY JOURNAL
- Plasma Exchange to Rescue Patients with Autoantibodies Against Type I Interferons and Life-Threatening COVID-19 Pneumonia
- (2021) Nicolas de Prost et al. JOURNAL OF CLINICAL IMMUNOLOGY
- Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial
- (2021) Christopher C Butler et al. LANCET
- Role of ivermectin in the prevention of SARS-CoV-2 infection among healthcare workers in India: A matched case-control study
- (2021) Priyamadhaba Behera et al. PLoS One
- Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study
- (2020) Xiaobo Yang et al. Lancet Respiratory Medicine
- Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods
- (2020) Canrong Wu et al. Acta Pharmaceutica Sinica B
- Trained Immunity: a Tool for Reducing Susceptibility to and the Severity of SARS-CoV-2 Infection
- (2020) Mihai G. Netea et al. CELL
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
- (2020) Markus Hoffmann et al. CELL
- The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID‐19
- (2020) Virginia D. Schmith et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- COVID ‐19: lambda interferon against viral load and hyperinflammation
- (2020) Evangelos Andreakos et al. EMBO Molecular Medicine
- Famotidine Use is Associated with Improved Clinical Outcomes in Hospitalized COVID-19 Patients: A Propensity Score Matched Retrospective Cohort Study
- (2020) Daniel E. Freedberg et al. GASTROENTEROLOGY
- Aminoquinolines against coronavirus disease 2019 (COVID-19): chloroquine or hydroxychloroquine
- (2020) Zahra Sahraei et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area
- (2020) Safiya Richardson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- SARS-CoV-2: a storm is raging
- (2020) Savannah F. Pedersen et al. JOURNAL OF CLINICAL INVESTIGATION
- Deployment of convalescent plasma for the prevention and treatment of COVID-19
- (2020) Evan M. Bloch et al. JOURNAL OF CLINICAL INVESTIGATION
- Triple combination of interferon beta-1b, lopinavir–ritonavir, and ribavirin in the treatment of patients admitted to hospital with COVID-19: an open-label, randomised, phase 2 trial
- (2020) Ivan Fan-Ngai Hung et al. LANCET
- Pulmonary Vascular Endothelialitis, Thrombosis, and Angiogenesis in Covid-19
- (2020) Maximilian Ackermann et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Interferon-α2b Treatment for COVID-19
- (2020) Qiong Zhou et al. Frontiers in Immunology
- Experimental Treatment with Favipiravir for COVID-19: An Open-Label Control Study
- (2020) Qingxian Cai et al. Engineering
- COVID-19 attack rate in HIV-infected patients and in PrEP users
- (2020) Caroline Charre et al. AIDS
- Ivermectin and COVID-19: A report in Antiviral Research, widespread interest, an FDA warning, two letters to the editor and the authors' responses
- (2020) Mike Bray et al. ANTIVIRAL RESEARCH
- The FDA-approved drug ivermectin inhibits the replication of SARS-CoV-2 in vitro
- (2020) Leon Caly et al. ANTIVIRAL RESEARCH
- The Impact of the COVID-19 “Infodemic” on Drug-Utilization Behaviors: Implications for Pharmacovigilance
- (2020) Marco Tuccori et al. DRUG SAFETY
- Association between famotidine use and COVID-19 severity in Hong Kong: a territory-wide study
- (2020) Ka Shing Cheung et al. GASTROENTEROLOGY
- Ribavirin, Remdesivir, Sofosbuvir, Galidesivir, and Tenofovir against SARS-CoV-2 RNA dependent RNA polymerase (RdRp): A molecular docking study
- (2020) Abdo A. Elfiky LIFE SCIENCES
- Nitazoxanide/azithromycin combination for COVID-19: A suggested new protocol for early management
- (2020) Mina T. Kelleni PHARMACOLOGICAL RESEARCH
- Repurposing the mucolytic cough suppressant and TMPRSS2 protease inhibitor bromhexine for the prevention and management of SARS-CoV-2 infection
- (2020) Roberto Maggio et al. PHARMACOLOGICAL RESEARCH
- Inhaled nitric oxide therapy in acute bronchiolitis: A multicenter randomized clinical trial
- (2020) Aviv Goldbart et al. Scientific Reports
- Role of Lopinavir/Ritonavir in the Treatment of Covid-19: A Review of Current Evidence, Guideline Recommendations, and Perspectives
- (2020) Simone Meini et al. Journal of Clinical Medicine
- A prospective, randomized, open-label trial of early versus late favipiravir in hospitalized patients with COVID-19
- (2020) Yohei Doi et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Dose Prediction for Repurposing Nitazoxanide in SARS‐CoV‐2 Treatment or Chemoprophylaxis
- (2020) Rajith K.R. Rajoli et al. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
- Use of Ivermectin is Associated with Lower Mortality in Hospitalized Patients with COVID-19 (ICON study)
- (2020) Juliana Cepelowicz Rajter et al. CHEST
- Bromhexine Hydrochloride Tablets for the Treatment of Moderate COVID‐19: An Open‐Label Randomized Controlled Pilot Study
- (2020) Ting Li et al. CTS-Clinical and Translational Science
- Re-recognizing bromhexine hydrochloride: pharmaceutical properties and its possible role in treating pediatric COVID-19
- (2020) Qibo Fu et al. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY
- Effect of Dexamethasone on Days Alive and Ventilator-Free in Patients With Moderate or Severe Acute Respiratory Distress Syndrome and COVID-19
- (2020) Bruno M. Tomazini et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A mouse-adapted model of SARS-CoV-2 to test COVID-19 countermeasures
- (2020) Kenneth H. Dinnon et al. NATURE
- Favipiravir at high doses has potent antiviral activity in SARS-CoV-2−infected hamsters, whereas hydroxychloroquine lacks activity
- (2020) Suzanne J. F. Kaptein et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Benefits and adverse effects of hydroxychloroquine, methotrexate and colchicine: searching for repurposable drug candidates
- (2020) Durga Prasanna Misra et al. RHEUMATOLOGY INTERNATIONAL
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- Rapid incorporation of Favipiravir by the fast and permissive viral RNA polymerase complex results in SARS-CoV-2 lethal mutagenesis
- (2020) Ashleigh Shannon et al. Nature Communications
- Biological, molecular and pharmacological characteristics of chloroquine, hydroxychloroquine, convalescent plasma, and remdesivir for COVID-19 pandemic: A comparative analysis
- (2020) Sultan Ayoub Meo et al. JOURNAL OF KING SAUD UNIVERSITY SCIENCE
- Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial
- (2020) Khalil Ansarin et al. BioImpacts
- Proton pump inhibitor or famotidine use and severe COVID-19 disease: a propensity score-matched territory-wide study
- (2020) Jiandong Zhou et al. GUT
- A COVID-19 prophylaxis? Lower incidence associated with prophylactic administration of ivermectin
- (2020) Martin D. Hellwig et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors
- (2020) Rachel P. M. Abrams et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Efficacy and safety of favipiravir, an oral RNA-dependent RNA polymerase inhibitor, in mild-to-moderate COVID-19: A randomized, comparative, open-label, multicenter, phase 3 clinical trial
- (2020) Zarir F. Udwadia et al. INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES
- Lopinavir/ritonavir: Repurposing an old drug for HIV infection in COVID-19 treatment
- (2020) Paola Magro et al. Biomedical Journal
- Lethal mutagenesis of Rift Valley fever virus induced by favipiravir
- (2019) Belén Borrego et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Influenza virus polymerase inhibitors in clinical development
- (2019) Frederick G. Hayden et al. CURRENT OPINION IN INFECTIOUS DISEASES
- Inhibitors of nuclear transport
- (2019) David A Jans et al. CURRENT OPINION IN CELL BIOLOGY
- Favipiravir as a potential countermeasure against neglected and emerging RNA viruses
- (2018) Leen Delang et al. ANTIVIRAL RESEARCH
- Colchicine Pharmacokinetics and Mechanism of Action
- (2018) Christos Angelidis et al. CURRENT PHARMACEUTICAL DESIGN
- Doxycycline as an anti-inflammatory agent: updates in dermatology
- (2017) M. Henehan et al. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY
- Neurovirulent Murine Coronavirus JHM.SD Uses Cellular Zinc Metalloproteases for Virus Entry and Cell-Cell Fusion
- (2017) Judith M. Phillips et al. JOURNAL OF VIROLOGY
- The end of a dogma: the safety of doxycycline use in young children for malaria treatment
- (2017) Tiphaine Gaillard et al. MALARIA JOURNAL
- Favipiravir (T-705), a broad spectrum inhibitor of viral RNA polymerase
- (2017) Yousuke FURUTA et al. PROCEEDINGS OF THE JAPAN ACADEMY SERIES B-PHYSICAL AND BIOLOGICAL SCIENCES
- Use of colchicine in pregnancy: a systematic review and meta-analysis
- (2017) Praveen L Indraratna et al. RHEUMATOLOGY
- The EULAR points to consider for use of antirheumatic drugs before pregnancy, and during pregnancy and lactation
- (2016) Carina Götestam Skorpen et al. ANNALS OF THE RHEUMATIC DISEASES
- Identification of Nafamostat as a Potent Inhibitor of Middle East Respiratory Syndrome Coronavirus S Protein-Mediated Membrane Fusion Using the Split-Protein-Based Cell-Cell Fusion Assay
- (2016) Mizuki Yamamoto et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovery of berberine, abamectin and ivermectin as antivirals against chikungunya and other alphaviruses
- (2016) Finny S. Varghese et al. ANTIVIRAL RESEARCH
- Thiazolides Elicit Anti-Viral Innate Immunity and Reduce HIV Replication
- (2016) Daria Trabattoni et al. Scientific Reports
- Nitazoxanide, a new drug candidate for the treatment of Middle East respiratory syndrome coronavirus
- (2016) Jean-François Rossignol Journal of Infection and Public Health
- Colchicine Use During Breastfeeding
- (2015) Tina Herscovici et al. Breastfeeding Medicine
- Efficacy of Favipiravir (T-705) in Rabies Postexposure Prophylaxis
- (2015) Kentaro Yamada et al. JOURNAL OF INFECTIOUS DISEASES
- Post-exposure prophylaxis against Ebola virus disease with experimental antiviral agents: a case-series of health-care workers
- (2015) Michael Jacobs et al. LANCET INFECTIOUS DISEASES
- Nitazoxanide: A first-in-class broad-spectrum antiviral agent
- (2014) Jean-François Rossignol ANTIVIRAL RESEARCH
- The BCG replacement vaccine VPM1002: from drawing board to clinical trial
- (2014) Stefan HE Kaufmann et al. Expert Review of Vaccines
- Favipiravir (T-705), a novel viral RNA polymerase inhibitor
- (2013) Yousuke Furuta et al. ANTIVIRAL RESEARCH
- Inhibitory effect of doxycycline against dengue virus replication in vitro
- (2013) Hussin A. Rothan et al. ARCHIVES OF VIROLOGY
- Low-dose Interferon-α Treatment Improves Survival and Inflammatory Responses in a Mouse Model of Fulminant Acute Respiratory Distress Syndrome
- (2013) Daisuke Kudo et al. INFLAMMATION
- Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome
- (2013) Takuma Misawa et al. NATURE IMMUNOLOGY
- The effect of intravenous interferon-beta-1a (FP-1201) on lung CD73 expression and on acute respiratory distress syndrome mortality: an open-label study
- (2013) Geoff Bellingan et al. Lancet Respiratory Medicine
- Nitazoxanide suppresses IL-6 production in LPS-stimulated mouse macrophages and TG-injected mice
- (2012) Seong Keun Hong et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Clinical Perspectives with Long-Term Pulsed Inhaled Nitric Oxide for the Treatment of Pulmonary Arterial Hypertension
- (2012) Robyn J. Barst et al. Pulmonary Circulation
- Evidence that TMPRSS2 Activates the Severe Acute Respiratory Syndrome Coronavirus Spike Protein for Membrane Fusion and Reduces Viral Control by the Humoral Immune Response
- (2011) I. Glowacka et al. JOURNAL OF VIROLOGY
- Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature
- (2010) Michael O. Griffin et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- Single-dose intranasal administration with mDEF201 (adenovirus vectored mouse interferon-alpha) confers protection from mortality in a lethal SARS-CoV BALB/c mouse model
- (2010) Yohichi Kumaki et al. ANTIVIRAL RESEARCH
- Efficient Activation of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein by the Transmembrane Protease TMPRSS2
- (2010) S. Matsuyama et al. JOURNAL OF VIROLOGY
- A randomized controlled trial of low-dose recombinant human interferons α-2b nasal spray to prevent acute viral respiratory infections in military recruits
- (2010) LuLu Gao et al. VACCINE
- The Anti-Hepatitis C Agent Nitazoxanide Induces Phosphorylation of Eukaryotic Initiation Factor 2α Via Protein Kinase Activated by Double-Stranded RNA Activation
- (2009) Menashe Elazar et al. GASTROENTEROLOGY
- Inhibitory effects of ivermectin on nitric oxide and prostaglandin E2 production in LPS-stimulated RAW 264.7 macrophages
- (2009) Xuemei Zhang et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Chemical biology of tetracycline antibioticsThis paper is one of a selection of papers published in this Special Issue, entitled CSBMCB — Systems and Chemical Biology, and has undergone the Journal's usual peer review process.
- (2008) Bijan Zakeri et al. Biochemistry and Cell Biology
- Ivermectin inhibits LPS-induced production of inflammatory cytokines and improves LPS-induced survival in mice
- (2008) X. Zhang et al. INFLAMMATION RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now